BACE1 and Alzheimer disease: Thisstudy demonstrated that serum miR-149 is decreased in AD patients and serves asa candidate diagnostic biomarker, and that the overexpression of miR-149 maysuppress Aβ accumulation and promote neuronal viability by targeting BACE1 in ADmodel cells.